Trials / Unknown
UnknownNCT05651074
Assessment of the Effect of Omeprazole on Vicagrel in Healthy Subjects
A Pharmacokinetic/Pharmacodynamic Study to Evaluate the Effect of Omeprazole of Vicagrel in Healthy Subjects
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of the study is to evaluate the effects of omeprazole on the PK and PD of a single dose of vicagrel in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vicagrel and omeprazole | 18 mg vicagrel capsules and 40 mg omeprazole magnesium enteric-coated tablets |
Timeline
- Start date
- 2022-11-14
- Primary completion
- 2023-02-01
- Completion
- 2023-04-01
- First posted
- 2022-12-14
- Last updated
- 2023-01-31
Locations
1 site across 1 country: China
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05651074. Inclusion in this directory is not an endorsement.